transfizyon

Transfizyon is the Turkish term for the medical procedure of transfusing blood or blood products into a patient’s circulation to replace lost components such as red blood cells, plasma, or platelets. The practice dates back to the early 20th century, when the first successful human blood transfusions were performed using whole blood. Since then, advances in blood typing, cross‑matching, and storage have greatly improved safety and expanded the applications of transfizyon.

In clinical practice transfizyon is indicated for conditions that cause significant blood loss or hemolysis, such as trauma, surgical bleeding, severe anemia, and certain hematologic disorders. It can also be used to correct specific deficiencies, for example, platelet transfusions in thrombocytopenia or plasma transfusions in coagulation factor deficiencies. Guidelines recommend that transfusions be guided by laboratory parameters—hemoglobin or hematocrit levels, coagulation studies, and patient symptoms—to avoid unnecessary exposure.

The procedure involves drawing a sample from the donor, testing for blood type and infectious markers (HIV, hepatitis B and C, syphilis, and others), and preparing the product under sterile conditions. The transfused blood may be whole blood or a component such as packed red cells, fresh frozen plasma, or platelets, each stored under specific temperature controls. Administration is performed through an intravenous line with careful monitoring of vital signs and allergic reactions.

Potential adverse effects include febrile non‑hemolytic reactions, allergic or anaphylactic responses, transfusion‑related acute lung injury, circulatory overload, and transmission of infections, although the latter has become exceedingly rare in countries with rigorous screening protocols. Post‑transfusion monitoring typically focuses on hematologic parameters and signs of complication.

In Turkey, transfizyon is regulated by the Ministry of Health and the Turkish Society of Blood Transfusion and Cellular Therapy. Blood banks operate under strict quality management systems, and training for medical personnel includes mandatory certification in transfusion medicine. Legally, the donor must give informed consent, and recipients are required to undergo pre‑transfusion testing to ensure compatibility. The Turkish system emphasizes donor safety, recipient compatibility, and continuous audit to maintain the highest safety standards in transfizyon practice.